You are here

MASCC Miami Florida June 2014: Dr Florian Scotté

Kidney Failure a Risk Factor for Febrile Neutropenia in NHL

By Vincent Launay-Vacher

Li X et al., abstr. 0230

This American case-control study examined types of comorbidity that are associated with an increased incidence of febrile neutropenia in 1,540 breast cancer (BC) patients and 869 non-Hodgkin lymphoma (NHL) patients. Between 2007 and 2011, each patient that presented with febrile neutropenia during the first chemotherapy treatment was matched with 4 patients with respect to the type of cancer, metastases, chemotherapy regime, age bracket, and sex. The analysis was adjusted for potential confounding factors (GCSF (Granulocyte-Colony Stimulating Factor) prophylaxis, previous hospitalization, surgery, etc.).

In breast cancer patients, osteoarticular inflammation was associated with an increase in the risk of the onset of febrile neutropenia (Adjusted Odds Ratio [aOR] = 1.85; [1.07-3.18]). In NHL patients, kidney failure was identified as the risk factor for febrile neutropenia in this study (aOR = 2.25; [1.23-4.11].

 

NHL and breast cancer: risk of febrile neutropenia as it relates to comorbidity at the start of chemotherapy

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

NEW! Free access to the digital version of a new publication in Cancer Supportive Care


Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share